Literature DB >> 9800792

Evaluation of treatment modalities for thoracic empyema: a cost-effectiveness analysis.

V H Thourani1, K M Brady, K A Mansour, J I Miller, R B Lee.   

Abstract

BACKGROUND: Empyema thoracis is treated with a multitude of therapeutic options. Optimal therapy and cost-containment requires selection of the most appropriate initial intervention.
METHODS: A retrospective review of treatment modalities was performed on 77 patients diagnosed with empyema thoracis from 1990 to 1997 at one institution. Mean age was 59 years (range, 21 to 90 years); 52 were men and 25 were women.
RESULTS: Sixty-five percent (50/77) were parapneumonic and 68% (52/77) were multiloculated. Treatment modalities were as follows: group 1, antibiotics only (n = 4); group 2, primary intervention: image-directed catheter (n = 20) or tube thoracostomy (n = 24); and group 3, secondary intervention: decortication (n = 17), rib resection or muscle interposition (n = 12). Thirty-four percent (9/20 image-directed catheter and 8/24 tube thoracostomy) had failure of initial intervention. Patients undergoing decortication more often had multiloculated empyema thoracis (16 of 17) compared with those undergoing image-directed catheters (8 of 20) or tube thoracotomy (16 of 24). Length of stay was reduced for decortication patients (17 days) compared with those having image-directed catheters (21.8 days), failed image-directed catheters (29.7 days), or tube thoracostomies (19.6 days). Hospital charges per patient between decortication and image-directed catheter ($34,770.79 versus $37,869.41) were comparable, but charges were significantly decreased in decortication patients as compared with failed image-directed catheters ($55,609.32; p < 0.05).
CONCLUSIONS: Our series revealed that early decortication has charges similar to those of primary intervention (image-directed catheter or tube thoracostomy) but is more cost-effective than failed image-directed catheter. We advocate the use of early surgical intervention as the most optimal and cost-effective initial modality for the treatment of empyema thoracis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800792     DOI: 10.1016/s0003-4975(98)00767-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Change in Pulmonary Function Following Decortication for Chronic Pleural Empyema.

Authors:  Sujith Varghese Abraham; Prashant Chikkahonnaiah
Journal:  Turk Thorac J       Date:  2020-01-01

Review 2.  Surgical treatment of chronic empyema.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

3.  A simple weighted scoring system to guide surgical decision-making in patients with parapneumonic pleural effusion.

Authors:  Che-Chia Chang; Tzu-Ping Chen; Chi-Hsiao Yeh; Pin-Fu Huang; Yao-Chang Wang; Shun-Ying Yin
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Management of intrathoracic defects.

Authors:  Hung-Chi Chen; Steven John Lo; Joo Hyoung Kim
Journal:  Semin Plast Surg       Date:  2011-02       Impact factor: 2.314

5.  Pleural effusion adenosine deaminase: a candidate biomarker to discriminate between Gram-negative and Gram-positive bacterial infections of the pleural space.

Authors:  Ruolin Li; Junli Wang; Xinfeng Wang; Maoshui Wang
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

6.  Perioperative implications of thoracic decortications: a retrospective cohort study.

Authors:  Jay Gorman; Duane Funk; Sadeesh Srinathan; John Embil; Linda Girling; Stephen Kowalski
Journal:  Can J Anaesth       Date:  2017-05-10       Impact factor: 5.063

7.  Computed tomography-guided catheter drainage with urokinase and ozone in management of empyema.

Authors:  Bing Li; Chuan Liu; Yang Li; Han-Feng Yang; Yong Du; Chuan Zhang; Hou-Jun Zheng; Xiao-Xue Xu
Journal:  World J Radiol       Date:  2017-04-28

8.  Open thoracotomy and decortication for chronic empyema.

Authors:  Rafael Andrade-Alegre; Juan D Garisto; Salomón Zebede
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

9.  Is open decortication superior to fibrinolytic therapy as a first line treatment in the management of pleural empyema?

Authors:  Sultan Ahmed; Hammad Azam; Imran Basheer
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.